Pathos AI has launched a $400 million funding round and already raised nearly $283 million. The Chicago-based startup formed ...

The company's approved ANDA is therapeutically equivalent to AstraZeneca Pharmaceuticals's Brilinta Tablets, 60 mg and 90 mg, it added.

The FDA pushed back its decision date on Cytokinetics heart drug, while AstraZeneca got Phase 3 trial results that could help ...

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

Alembic Pharmaceuticals receives FDA approval for Ticagrelor Tablets 60 mg and 90 mg, therapeutically equivalent to Brilinta.

Kuantyrov emphasized that the UK is one of Kazakhstan’s key trading partners and top investors, with total foreign direct ...

AstraZeneca's Breztri met primary goals in four asthma trials, including KALOS, LOGOS, LITHOS, and VATHOS, involving over ...

AstraZeneca said on Friday that the full results from the two trials will be shared with regulatory authorities and presented ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Akeso's first overall survival readout for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed ...

The screenings identified nearly 50,000 individuals with lung nodules considered high risk for cancer, leading to their ...

Alembic Pharmaceuticals has received USFDA approval to market generic Ticagrelor Tablets, a medication for preventing heart ...